SANOFI INDIA
|
The Current P/E Ratio of SANOFI INDIA is 29.74.
Share Price | ₹5,491.5 | Feb 01,2025 |
Market Cap | ₹12,630.5 Cr | |
Earnings-TTM | ₹424.7 Cr | TTM-Standalone Results |
Price/Earnings | 29.74x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SANOFI INDIA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹12,630.5 Cr] as on Feb 01,2025
(/) Earnings [ ₹424.7 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 29.74x ]
Thus, for SANOFI INDIA , the investors are currently willing to pay 29.74 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SANOFI INDIA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SANOFI INDIA over the last five years.
Historical PE (Price/Earnings) ratio chart of SANOFI INDIA
PE Ratio Performance Analysis for SANOFI INDIA
- SANOFI INDIA 's p/e ratio for fiscal years ending Dec2023 to Dec2019 averaged 30.14x.
- SANOFI INDIA 's operated at median p/e ratio of 30.76x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SANOFI INDIA 's p/e ratio peaked in Dec2020 at 40.06x.
- SANOFI INDIA 's p/e ratio hit its five-year low in Dec2021 of 19.22x.
How does SANOFI INDIA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SANOFI INDIA | 424.70 | 29.74 | 12,630.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 36.40 | 418,132.0 |
CIPLA LTD | 5,000.43 | 23.22 | 116,123.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 18.53 | 100,573.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.79 | 97,966.9 |
DIVIS LABORATORIES LTD | 1,836.00 | 81.29 | 149,254.0 |
MANKIND PHARMA LTD | 2,050.73 | 49.91 | 102,348.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 58.26 | 108,477.0 |
LUPIN LTD | 2,651.94 | 35.38 | 93,813.7 |
AUROBINDO PHARMA LTD | 3,598.83 | 18.45 | 66,385.6 |
ABBOTT INDIA LTD | 1,284.66 | 42.86 | 55,059.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SANOFI INDIA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.45x |
Max industry PE | 81.29x |
Median industry PE | 35.38x |
Average industry PE | 37.89x |
You may also like the below Video Courses